US-based Argon Medical Devices has commercially launched two inferior vena cava (IVC) filter retrieval kits in the US.

The newly launched products, Single-Loop and Triple-Loop retrieval kits have secured approval from the US Food and Drug Administration (FDA) and are ready for sale.

These products remove any retrievable IVC filter through a jugular approach.

Argon Medical Devices president and CEO George Leondis said: “We are excited to improve the IVC filter retrieval options available to our customers with the introduction of these new products.

“Our Single-Loop and Triple-Loop Retrieval Kits are the only two kits cleared by the FDA for removing any retrievable IVC filter from a jugular approach.

“These new products further demonstrate our dedication to our mission to improve the lives of patients and caregivers through the innovation of best-in-class medical devices.”

These retrieval kits feature a coil-reinforced outer sheath with the strength required to remove filter legs from the IVC wall.

The newly-launched products also include radiopaque bands on the distal end of the inner sheath, outer sheath and the fifteen-degree curved snare catheter for improved visualisation and directional control.

Weill Cornell Medical Center Dr David Trost said: “IVC filters are a safe and effective treatment for the prevention of pulmonary embolism (PE), however, they should be removed when the need for the filter subsides.

“I like that Argon’s new retrieval kits can be used on all retrievable IVC filters, regardless of brand, from the jugular vein, providing unique versatility.”

In 2017, Chinese company Shandong Weigao Group Medical Polymer (Shandong Weigao) had agreed to acquire Argon Medical Devices for $850m.